
Encompass Health Corporation
EHCNYSEHealthcareMedical - Care Facilities
Previous close
$120.31
−$0.60 · -0.50%
EHC company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
84
Deep Value
Momentum
50
Neutral
Sentiment
73
Bullish
Risk resilience
72
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteEncompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Mark J. Tarr
- Listed since
- Sep 24, 1986
- Employees
- 29,699
Market position
Day range
Current $120.31
52-week range
Current $120.31
- Open
- $121.01
- Previous close
- $120.91
- Volume
- 543.41K
- 0.56× average
- Average volume
- 978.71K
- Average daily volume
- Market cap
- 11.93B USD
- Beta
- 0.6
- Market reference 1
- 50-day average
- $111.05
- +8.34% above average
- 200-day average
- $106.92
- +12.52% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 13.28B USD
- P/E (TTM)
- 19.34×
- P/B (TTM)
- 4.58×
- P/S (TTM)
- 1.92×
- EV / EBITDA
- 9.46×
- Earnings yield
- 5.31%
- Free cash flow yield
- 4.12%
- Dividend yield
- 0.63%
Profitability & efficiency
- Gross margin
- 73.13%
- Operating margin
- 18.00%
- Net margin
- 10.01%
- Return on equity
- 23.22%
- Return on assets
- 7.99%
- Return on invested capital
- 13.28%
Financial health
- Debt / equity
- 1.09×
- Current ratio
- 1.08×
- Altman Z-score
- 3.46
- Piotroski F-score
- 8 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.94B USD | 5.37B USD | 4.8B USD | 4.35B USD | 4.01B USD |
| Cost of goods sold | 254.4M USD | 3.14B USD | 2.82B USD | 2.6B USD | 2.31B USD |
| Gross profit | 5.68B USD | 2.23B USD | 1.98B USD | 1.75B USD | 1.7B USD |
| Selling, general, and administrative | 3.41B USD | 266.5M USD | 258M USD | 209M USD | 228.5M USD |
| Operating expenses | 4.63B USD | 1.37B USD | 258M USD | 1.12B USD | 1.04B USD |
| Interest expense | 123.2M USD | 137.4M USD | 143.5M USD | 175.7M USD | 164.3M USD |
| Depreciation and amortization | 327.9M USD | 299.6M USD | 273.9M USD | 243.6M USD | 219.6M USD |
| Operating income | 1.05B USD | 864.5M USD | 1.72B USD | 630.2M USD | 659.4M USD |
| Net income | 566.2M USD | 455.7M USD | 352M USD | 271M USD | 412.2M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 100%
- 11 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +11.10%
- 11 comparable reports
- Latest EPS result
- 1.55
- Estimate 1.48 · Beat by 4.73%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
27 ratingsCorporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$0.70
2025 complete year-21.4% since 2020
2026 partial: $0.57
$0.891
2,020
$0.891
2,021
$0.8028
2,022
$0.60
2,023
$0.70
2,025
$0.57
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Oct 1, 2026 | $0.21Quarterly | Oct 1, 2026 | Oct 15, 2026 |
Dividend | Jul 1, 2026 | $0.19Quarterly | Jul 1, 2026 | Jul 15, 2026 |
Dividend | Apr 1, 2026 | $0.19Irregular | Apr 1, 2026 | Apr 15, 2026 |
Dividend | Jan 2, 2026 | $0.19Quarterly | Jan 2, 2026 | Jan 15, 2026 |
Dividend | Oct 1, 2025 | $0.19Quarterly | Oct 1, 2025 | Oct 15, 2025 |
Dividend | Jul 1, 2025 | $0.17Quarterly | Jul 1, 2025 | Jul 15, 2025 |
Ex-dividend Oct 1, 2026
$0.21
Quarterly
Record Oct 1, 2026 · Payment Oct 15, 2026
Ex-dividend Jul 1, 2026
$0.19
Quarterly
Record Jul 1, 2026 · Payment Jul 15, 2026
Ex-dividend Apr 1, 2026
$0.19
Irregular
Record Apr 1, 2026 · Payment Apr 15, 2026
Ex-dividend Jan 2, 2026
$0.19
Quarterly
Record Jan 2, 2026 · Payment Jan 15, 2026
Ex-dividend Oct 1, 2025
$0.19
Quarterly
Record Oct 1, 2025 · Payment Oct 15, 2025
Ex-dividend Jul 1, 2025
$0.17
Quarterly
Record Jul 1, 2025 · Payment Jul 15, 2025
EHC peers
ETFs holding EHC
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Mid-Cap ETFIJH418.6M0.33%125.92B USD0.05%$76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI351.05M0.02%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB253.21M0.14%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR160.88M0.23%68.3B USD0.05%$249.18+0.68%
Vanguard Extended Market ETFVXF126.84M0.13%93.7B USD0.05%$245.53+0.82%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY87.84M0.33%26.72B USD0.23%$699.6+0.48%
iShares S&P Mid-Cap 400 Growth ETFIJK70.58M0.62%10.95B USD0.16%$115.45+0.37%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD62.31M0.33%18.77B USD0.03%$67.27+0.52%
iShares Core S&P Mid-Cap ETFIJH- Market value
- 418.6M
- Weight
- 0.33%
- AUM
- 125.92B USD
- Expense ratio
- 0.05%
- Price / 1D
- $76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 351.05M
- Weight
- 0.02%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 253.21M
- Weight
- 0.14%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 160.88M
- Weight
- 0.23%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Extended Market ETFVXF- Market value
- 126.84M
- Weight
- 0.13%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY- Market value
- 87.84M
- Weight
- 0.33%
- AUM
- 26.72B USD
- Expense ratio
- 0.23%
- Price / 1D
- $699.6+0.48%
iShares S&P Mid-Cap 400 Growth ETFIJK- Market value
- 70.58M
- Weight
- 0.62%
- AUM
- 10.95B USD
- Expense ratio
- 0.16%
- Price / 1D
- $115.45+0.37%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD- Market value
- 62.31M
- Weight
- 0.33%
- AUM
- 18.77B USD
- Expense ratio
- 0.03%
- Price / 1D
- $67.27+0.52%
Continue in GoAI
Research EHCresearch.disclaimer





